Detalhe da pesquisa
1.
Interferon and myeloproliferative neoplasms: Evolving therapeutic approaches.
Bioessays
; 45(3): e2200203, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36642848
2.
Clinical outcomes of hypomethylating agents plus Venetoclax as frontline treatment in patients 75 years and older with acute myeloid leukemia: Real-world data from eight US academic centers.
Am J Hematol
; 99(4): 606-614, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38342997
3.
Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphoma.
Blood Adv
; 7(19): 5771-5779, 2023 10 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37327113
4.
Two transcription factors can direct three photoreceptor outcomes from rod precursor cells in mouse retinal development.
J Neurosci
; 31(31): 11118-25, 2011 Aug 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21813673
5.
PRC2 Inhibitors Overcome Glucocorticoid Resistance Driven by NSD2 Mutation in Pediatric Acute Lymphoblastic Leukemia.
Cancer Discov
; 12(1): 186-203, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34417224
6.
An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
Oncogene
; 38(5): 671-686, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30171259
7.
The Role of Nuclear Receptor-Binding SET Domain Family Histone Lysine Methyltransferases in Cancer.
Cold Spring Harb Perspect Med
; 7(6)2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28193767
8.
Loss of fibrinogen in zebrafish results in symptoms consistent with human hypofibrinogenemia.
PLoS One
; 8(9): e74682, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24098662